Company
A new era for human health
Welcome to our Canadian website. GSK is a global biopharma company with the ambition and purpose to unite science, technology and talent to get ahead of disease together.
A signal for change
Our strategy
We make innovative vaccines and specialty medicines to prevent and treat disease. Our R&D focuses on the science of the immune system, human genetics and advanced technologies.Our R&D focus is on four therapeutic areas: infectious diseases, HIV, oncology, and immunology.
$3 mil +
contributed over the last 20 years to support the hospice palliative care movement in Canada
GSK Global links
Visit our Global site for additional features
Press releases
- Blenrep (belantamab mafodotin) combinations approved in Canada for the treatment of relapsed/refractory multiple myeloma
- Jemperli receives positive funding recommendations from CDA-AMC and INESSS in all adult patients with primary advanced or first recurrent endometrial cancer
- GSK and Dalhousie University Collaborate to Address Health Equity Gaps through the GSK Vaccinology and Health Equity Fellowship Award
